Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Javier, Castrodeza Sanz"'
Autor:
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Jessica E. Atwell, Javier Castrodeza Sanz, José M. Eiros, Ivan Sanz-Muñoz
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 11, Pp 2395-2413 (2024)
Abstract Introduction We aimed to describe the risk profile of RSV infections among children aged ≤ 24 months in Valladolid from January 2010 to August 2022 and to compare them with influenza and COVID-19 controls. Methods We conducted a retrospect
Externí odkaz:
https://doaj.org/article/965a1f43bddf40ed920a4f02a0bc6934
Autor:
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M. Eiros, Ivan Sanz-Muñoz
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 9, Pp 1983-1999 (2024)
Abstract Introduction We aimed to describe the risk profile of respiratory syncytial virus (RSV) infections among adults ≥ 60 years in Valladolid from January 2010 to August 2022, and to compare them with influenza and COVID-19 controls. Methods Th
Externí odkaz:
https://doaj.org/article/7fc09ac3b8824803a090a6f5eac3ff29
Autor:
Camino Prada-García, Marina Toquero-Asensio, Virginia Fernández-Espinilla, Cristina Hernán-García, Iván Sanz-Muñoz, Jose M. Eiros, Javier Castrodeza-Sanz
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1162 (2024)
Background/Objectives: The experience of the COVID-19 pandemic has turned the spotlight on the importance of public health measures and disease prevention. Despite this, the acceptance of influenza vaccination has remained low in most countries (and
Externí odkaz:
https://doaj.org/article/76b05103c20b49349c845083c713a1bd
Publikováno v:
Open Respiratory Archives, Vol 6, Iss 2, Pp 100320- (2024)
Nirsevimab therapy has the potential to revolutionize infant respiratory syncytial virus (RSV) prophylaxis. But other populations suffering RSV, such the elderly or those over 60, may also be protected by using this novel antibody in the infant group
Externí odkaz:
https://doaj.org/article/cc97af7bb87a4f768f2c2cd4293a44fd
Autor:
Iván Sanz-Muñoz, Laura Sánchez-dePrada, Javier Sánchez-Martínez, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz, José María Eiros
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 3, Pp 656-658 (2023)
Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age. Low antibody
Externí odkaz:
https://doaj.org/article/03fd1b8d6a8a40659950ed35be609f42
Autor:
Iván Sanz-Muñoz, Conrado Lajara, Javier Sánchez-Martínez, Camino Prada-García, Silvia Rojo-Rello, Marta Domínguez-Gil, Virginia Fernández-Espinilla, Cristina Hernán-García, José M. Eiros-Bachiller, Asunción Caminero-Pérez, Yolanda Marcos-López, Luis Teso-Fernández, José Ignacio Echarren, Javier Castrodeza-Sanz, José M. Eiros
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
The aim of this work is to describe the dynamics of influenza antibodies after vaccination in adults. We conducted a case-cohort serological study in the automobile manufacturing plants of the Renault España S.A. group in Valladolid and Palencia (Sp
Externí odkaz:
https://doaj.org/article/8b78b4bbea2b4c27831a204def7e08de
Autor:
Camino Prada-García, Marina Toquero-Asensio, Virginia Fernández-Espinilla, Cristina Hernán-García, Iván Sanz-Muñoz, María Dolores Calvo-Nieves, Jose M. Eiros, Javier Castrodeza-Sanz
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1514 (2023)
Seasonal influenza is an acute respiratory infection caused by the influenza virus which constitutes a significant public health issue associated with high morbidity and mortality. The aim of this study was to investigate changes in attitudes, percep
Externí odkaz:
https://doaj.org/article/ea16cf78c7ff42269e95949b313fdef6
Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
Autor:
Iván Sanz-Muñoz, Rosa López-Mongil, Javier Sánchez-Martínez, Laura Sánchez-de Prada, Marta Domínguez-Gil González, Diana Pérez-SanJose, Silvia Rojo-Rello, Cristina Hernán-García, Virginia Fernández-Espinilla, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz, José María Eiros
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe third dose of the COVID-19 vaccine is especially necessary in people over 65 years of age due to their lower immune response.MethodsWe designed a multicentre, prospective observational study including 98 people ≤65 years old who liv
Externí odkaz:
https://doaj.org/article/2ad1b5680b484a6f87da88c4b0a905f4
Publikováno v:
Vaccines, Vol 11, Iss 5, p 902 (2023)
In recent decades, the improvement of traditional vaccines has meant that we have moved from inactivated whole virus vaccines, which provoke a moderate immune response but notable adverse effects, to much more processed vaccines such as protein subun
Externí odkaz:
https://doaj.org/article/bbc50547a0124eb09be243ffa1f01c1e
Autor:
Laura Sánchez-de Prada, Raúl Ortiz de Lejarazu-Leonardo, Javier Castrodeza-Sanz, Eduardo Tamayo-Gómez, José María Eiros-Bouza, Iván Sanz-Muñoz
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundSex differences in immune responses are well known. However, the humoral response in males and females in the case of influenza vaccination is yet to be characterized since studies have shown uneven results.MethodsA retrospective study was
Externí odkaz:
https://doaj.org/article/4c8b3fea2faf42dfadde1c4ad291b3fb